ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

In Vitro Pharmacology Scientist at Isomorphic Labs - ApplyBlast

In Vitro Pharmacology Scientist

Isomorphic Labs

2 months ago

4.4 on Glassdoor

Cambridge, Massachusetts, United States

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Isomorphic Labs is seeking an experienced in‑vitro pharmacologist to design and implement biological screening cascades, guide assay development, and bridge computational predictions with experimental validation across oncology, immunology, and partnership programs. The role collaborates closely with AI/ML, medicinal chemistry, structural biology, and translational teams to advance drug design projects from early discovery to candidate selection.

Responsibilities

Design comprehensive biological screening cascades for drug design programs
Guide development and implementation of biophysical, biochemical, and cellular assays
Collaborate with CROs and cross‑functional teams to deliver high‑quality biological data

Skills

Qualifications

Ph.D. in Pharmacology, Biochemistry, Cell Biology, Biophysics, or related scientific discipline

About Isomorphic Labs

isomorphiclabs.com

Headquarters

London, England, United Kingdom

Company Size

51-200 employees

Founded

2021

View Profile

Isomorphic Labs is an AI-driven drug discovery company that applies frontier machine learning to reimagine the drug discovery process. Building on advances such as DeepMind’s AlphaFold, it uses protein-structure prediction, generative modeling, and computational biology to uncover deeper biological insights, design candidate molecules, and accelerate target selection. The company develops an integrated computational platform and partners with biopharma to translate in silico predictions into experimental programs aimed at faster, de‑risked development of life‑changing medicines. Its teams combine machine learning, biology, and chemistry expertise to shorten discovery timelines and increase the pace of therapeutic breakthroughs.